BM18

Patient-derived xenografts and organoids model therapy response in prostate cancer

This proof-of-principle study provides a preclinical tool to screen drug responses to standard-of-care and newly identified, repurposed compounds.

Stroma transcriptomic and proteomic profile of prostate cancer metastasis xenograft models reveals conservation of bone microenvironment signatures

Selected stromal markers of osteoblastic PCa indicate a conserved mechanism of tumor cells to induce a stromal pre-metastatic signature with high potential prognostic or diagnostic value.

Patient-derived xenografts and organoids model therapy response in prostate cancer

This proof-of-principle study provides a preclinical tool to screen drug responses to standard-of-care and newly identified, repurposed compounds.